Improving the Assessment of Heart Toxicity for All New Drugs Through Translational Regulatory Science. Issue 5 (12th December 2013)
- Record Type:
- Journal Article
- Title:
- Improving the Assessment of Heart Toxicity for All New Drugs Through Translational Regulatory Science. Issue 5 (12th December 2013)
- Main Title:
- Improving the Assessment of Heart Toxicity for All New Drugs Through Translational Regulatory Science
- Authors:
- Johannesen, L
Vicente, J
Gray, R A
Galeotti, L
Loring, Z
Garnett, C E
Florian, J
Ugander, M
Stockbridge, N
Strauss, D G - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Fourteen drugs have been removed from the market worldwide because they cause torsade de pointes. Most drugs that cause torsade can be identified by assessing whether they block the human <italic>ether à gogo</italic> related gene (hERG) potassium channel and prolong the QT interval on the electrocardiogram. In response, regulatory agencies require new drugs to undergo "thorough QT" studies. However, some drugs block hERG potassium channels and prolong QT with minimal torsade risk because they also block calcium and/or sodium channels. Through analysis of clinical and preclinical data from 34 studies submitted to the US Food and Drug Administration and by computer simulations, we demonstrate that by dividing the QT interval into its components of depolarization (QRS), early repolarization (<italic>J</italic>−<italic>T</italic><sub>peak</sub>), and late repolarization (<italic>T</italic><sub>peak</sub>−<italic>T</italic><sub>end</sub>), along with atrioventricular conduction delay (PR), it may be possible to determine which hERG potassium channel blockers also have calcium and/or sodium channel blocking activity. This translational regulatory science approach may enable innovative drugs that otherwise would have been labeled unsafe to come to market.</p> <p> <italic>Clinical Pharmacology &amp; Therapeutics</italic> (2014); <bold>95</bold> 5, 501–508. doi:<ext-link ext-link-type="doi"<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Fourteen drugs have been removed from the market worldwide because they cause torsade de pointes. Most drugs that cause torsade can be identified by assessing whether they block the human <italic>ether à gogo</italic> related gene (hERG) potassium channel and prolong the QT interval on the electrocardiogram. In response, regulatory agencies require new drugs to undergo "thorough QT" studies. However, some drugs block hERG potassium channels and prolong QT with minimal torsade risk because they also block calcium and/or sodium channels. Through analysis of clinical and preclinical data from 34 studies submitted to the US Food and Drug Administration and by computer simulations, we demonstrate that by dividing the QT interval into its components of depolarization (QRS), early repolarization (<italic>J</italic>−<italic>T</italic><sub>peak</sub>), and late repolarization (<italic>T</italic><sub>peak</sub>−<italic>T</italic><sub>end</sub>), along with atrioventricular conduction delay (PR), it may be possible to determine which hERG potassium channel blockers also have calcium and/or sodium channel blocking activity. This translational regulatory science approach may enable innovative drugs that otherwise would have been labeled unsafe to come to market.</p> <p> <italic>Clinical Pharmacology &amp; Therapeutics</italic> (2014); <bold>95</bold> 5, 501–508. doi:<ext-link ext-link-type="doi" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">10.1038/clpt.2013.238</ext-link></p> </abstract> … (more)
- Is Part Of:
- Clinical pharmacology & therapeutics. Volume 95:Issue 5(2014)
- Journal:
- Clinical pharmacology & therapeutics
- Issue:
- Volume 95:Issue 5(2014)
- Issue Display:
- Volume 95, Issue 5 (2014)
- Year:
- 2014
- Volume:
- 95
- Issue:
- 5
- Issue Sort Value:
- 2014-0095-0005-0000
- Page Start:
- 501
- Page End:
- 508
- Publication Date:
- 2013-12-12
- Subjects:
- Pharmacology -- Periodicals
Therapeutics -- Periodicals
615.5 - Journal URLs:
- http://www.nature.com/clpt/index.html ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1532-6535 ↗
http://www.nature.com/ ↗
http://firstsearch.oclc.org ↗
http://www.mosby.com/cpt ↗
http://www.sciencedirect.com/science/journal/00099236 ↗
http://www2.us.elsevierhealth.com/scripts/om.dll/serve?action=searchDB&searchdbfor=home&id=cp ↗ - DOI:
- 10.1038/clpt.2013.238 ↗
- Languages:
- English
- ISSNs:
- 0009-9236
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.330000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3687.xml